Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer
Oonagh Griffin, Sinead N. Duggan, Ronan Ryan, et al.
Pancreatology (2019) Vol. 19, Iss. 6, pp. 850-857
Closed Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
Thomas F. Stoop, Rutger T. Theijse, Leonard W. F. Seelen, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 2, pp. 101-124
Closed Access | Times Cited: 68
Manipulations of the gut microbiome alter chemotherapy-induced inflammation and behavioral side effects in female mice
Corena V. Grant, Brett R. Loman, Michael T. Bailey, et al.
Brain Behavior and Immunity (2021) Vol. 95, pp. 401-412
Open Access | Times Cited: 78
Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment
Raffaele De Luca, Luca Gianotti, Paolo Pedrazzoli, et al.
European Journal of Surgical Oncology (2022) Vol. 49, Iss. 3, pp. 542-549
Closed Access | Times Cited: 40
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment
Anne‐Laure Couderc, Évelyne Liuu, Pascaline Boudou‐Rouquette, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1193-1193
Open Access | Times Cited: 28
Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer
Raffaele Pezzilli, Riccardo Caccialanza, Gabriele Capurso, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 275-275
Open Access | Times Cited: 65
Skeletal Muscle Mass Change During Chemotherapy: A Systematic Review and Meta-analysis
Min Kyeong Jang, Chang Park, Susan Hong, et al.
Anticancer Research (2020) Vol. 40, Iss. 5, pp. 2409-2418
Open Access | Times Cited: 56
Clinical Implications of Malnutrition in the Management of Patients with Pancreatic Cancer: Introducing the Concept of the Nutritional Oncology Board
Giulia Rovesti, Filippo Valoriani, Margherita Rimini, et al.
Nutrients (2021) Vol. 13, Iss. 10, pp. 3522-3522
Open Access | Times Cited: 42
Chemotherapy-Induced Molecular Changes in Skeletal Muscle
Mafalda Barbosa Pedrosa, Samuel Barbosa, Rui Vitorino, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 905-905
Open Access | Times Cited: 18
Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma – analysis from SWOG S1505
Davendra Sohal, Robert D. Boutin, Leon Lenchik, et al.
Journal of Gastrointestinal Surgery (2024) Vol. 28, Iss. 3, pp. 232-235
Closed Access | Times Cited: 8
Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation
Patrick Naumann, Jonathan Eberlein, Benjamin Farnia, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1655-1655
Open Access | Times Cited: 47
Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance
Abakundana Nsenga Ariston Gabriel, Qinlian Jiao, Yvette Umwali, et al.
Pancreatology (2019) Vol. 20, Iss. 1, pp. 79-88
Open Access | Times Cited: 47
Daidzein alleviates cisplatin‐induced muscle atrophy by regulating Glut4/AMPK/FoxO pathway
Hong Zhang, Mengyi Chi, Linlin Chen, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 8, pp. 4363-4376
Closed Access | Times Cited: 39
Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer
Emmanuel Salinas-Miranda, Dominik Deniffel, Xin Dong, et al.
European Radiology (2021) Vol. 31, Iss. 11, pp. 8662-8670
Closed Access | Times Cited: 33
The impact of chemotherapy on adipose tissue remodeling: The molecular players involved in this tissue wasting
Samuel Barbosa, Mafalda Barbosa Pedrosa, Rita Ferreira, et al.
Biochimie (2024) Vol. 223, pp. 1-12
Open Access | Times Cited: 5
Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform
Ashok Narasimhan, Safi Shahda, Joshua K. Kays, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3787-3787
Open Access | Times Cited: 39
Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches
Chiara Cencioni, Ilaria Trestini, Geny Piro, et al.
Nutrients (2022) Vol. 14, Iss. 8, pp. 1542-1542
Open Access | Times Cited: 20
Silibinin Alleviates Muscle Atrophy Caused by Oxidative Stress Induced by Cisplatin through ERK/FoxO and JNK/FoxO Pathways
Mengyi Chi, Hong Zhang, Yaxian Wang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 19
Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature
Ester Oneda, Alberto Zaniboni
Journal of Clinical Medicine (2019) Vol. 8, Iss. 11, pp. 1922-1922
Open Access | Times Cited: 31
Sarcopenia in pancreatic cancer: Effect on patient outcomes
Moon Hyung Choi, Seung Bae Yoon
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 12, pp. 2302-2312
Open Access | Times Cited: 16
Early skeletal muscle mass decline is a prognostic factor in patients receiving gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer: a retrospective observational study
Yukari Suzuki, Kei Saito, Yousuke Nakai, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 3
Open Access | Times Cited: 10
Body composition parameters predict survival in pancreatic cancer—A retrospective multicenter analysis
Marko Damm, Ljupcho Efremov, Mustafa Jalal, et al.
United European Gastroenterology Journal (2023) Vol. 11, Iss. 10, pp. 998-1009
Open Access | Times Cited: 10
Breaking Down Cachexia: A Narrative Review on the Prevalence of Cachexia in Cancer Patients and Its Associated Risk Factors
Mahmathi Karuppannan, Fares Mohammed Saeed Muthanna, Fazlin Mohd Fauzi
Nutrition and Cancer (2024) Vol. 76, Iss. 5, pp. 404-418
Closed Access | Times Cited: 3
Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer
Oki Nakano, Hirokazu Kawai, Takamasa Kobayashi, et al.
Cancer Medicine (2021) Vol. 10, Iss. 13, pp. 4291-4301
Open Access | Times Cited: 22
Muscle and Adipose Wasting despite Disease Control: Unaddressed Side Effects of Palliative Chemotherapy for Pancreatic Cancer
Pamela Klassen, Vickie E. Baracos, Sunita Ghosh, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4368-4368
Open Access | Times Cited: 8
Linalool Prevents Cisplatin Induced Muscle Atrophy by Regulating IGF-1/Akt/FoxO Pathway
Hong Zhang, Mengyi Chi, Linlin Chen, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top